Rheumatoid Arthritis
- Safety and Efficacy of JAK Inhibitors for Treatment of RA
- Safe Withdrawal of Low-Dose Prednisolone After 2 Years in RA
- Low Cardiorespiratory Fitness Is a Significant Indicator of Increased Mortality Among Patients With RA
- Factors Affecting Physical Therapy Use Among Older Adults With RA
- No Differential Cardiovascular Disease Risk With DMARDs vs MTX Monotherapy in RA
- Future Fragility Fracture Linked to Rheumatoid Arthritis-Specific Risk Factors
- Abatacept Demonstrates Safety and Efficacy in RA, Regardless of Malignancy History
- Age, Sex, Smoking Status, and Presence of Autoantibodies Risk Factors for ILD Among Patients With RA
- Carotid Ultrasound May Help Identify Patients With RA at High-Risk for Subclinical Atherosclerosis
- Glucocorticoids May Increase Cardiovascular Event Risk Among Patients With RA
- Patients With Rheumatoid Arthritis More Prone to Experience COVID-19-Related Adverse Outcomes
- Lower Diabetes Risk Among Patients With RA Treated With Combination Therapy or Biologics
Features
More Rheumatoid Arthritis features
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
